Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.65 - $7.76 $453,531 - $622,902
-80,271 Closed
0 $0
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $673,971 - $884,040
-109,411 Reduced 57.68%
80,271 $556,000
Q1 2024

May 13, 2024

BUY
$7.61 - $8.63 $703,331 - $797,601
92,422 Added 95.03%
189,682 $1.46 Million
Q4 2023

Oct 21, 2024

BUY
$5.7 - $9.14 $44,192 - $70,862
7,753 Added 8.66%
97,260 $852,000
Q4 2023

Feb 07, 2024

BUY
$5.7 - $9.14 $44,192 - $70,862
7,753 Added 8.66%
97,260 $852,000
Q3 2023

Oct 21, 2024

SELL
$6.35 - $8.16 $344,500 - $442,696
-54,252 Reduced 37.74%
89,507 $652,000
Q3 2023

Nov 07, 2023

SELL
$6.35 - $8.16 $344,500 - $442,696
-54,252 Reduced 37.74%
89,507 $652,000
Q2 2023

Oct 21, 2024

BUY
$3.14 - $6.61 $176,967 - $372,532
56,359 Added 64.48%
143,759 $950,000
Q2 2023

Aug 07, 2023

BUY
$3.14 - $6.61 $176,967 - $372,532
56,359 Added 64.48%
143,759 $950,000
Q1 2023

Oct 21, 2024

BUY
$2.97 - $4.81 $21,173 - $34,290
7,129 Added 8.88%
87,400 $298,000
Q1 2023

May 03, 2023

BUY
$2.97 - $4.81 $52,325 - $84,742
17,618 Added 25.25%
87,400 $298,000
Q4 2022

Feb 13, 2023

SELL
$2.63 - $3.45 $71,320 - $93,557
-27,118 Reduced 27.99%
69,782 $193,000
Q3 2022

Nov 07, 2022

BUY
$2.71 - $4.22 $157,656 - $245,502
58,176 Added 150.23%
96,900 $278,000
Q2 2022

Aug 09, 2022

SELL
$3.17 - $5.0 $94,072 - $148,380
-29,676 Reduced 43.39%
38,724 $134,000
Q1 2022

May 12, 2022

SELL
$4.27 - $6.27 $94,366 - $138,567
-22,100 Reduced 24.42%
68,400 $322,000
Q4 2021

Feb 10, 2022

BUY
$5.7 - $8.48 $515,850 - $767,440
90,500 New
90,500 $547,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $983M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.